Logo
P

PLUS THERAPEUTICS

19 employees

Plus Therapeutics is focused on developing and delivering innovative cell-based therapies to improve the quality and length of life.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
cancer
ovarian cancer
nanomedicine
radioembolization
radiopharmaceutical
healthcare
breast cancer
growth
drug delivery
innovation
brain cancer
nanotechnology
oncology
Therapeutics
liposome
PSTV
liver cancer
Nasdaq
Medical
lung cancer
glioblastoma
rare disease

Date founded

2019

Funding rounds raised

Total raised

$27M

from 2 investors over 2 rounds

P

PLUS THERAPEUTICS raised $18M on August 17, 2022

Investors: Cancer Prevention and Research Institute of Texas

P

PLUS THERAPEUTICS raised $27M on July 1, 2013

Investors: Oxford Finance LLC

FAQ